FDA
approval
· 2020-07-21
FDA Approved: NEVIRAPINE — Supplemental Application (Micro Labs Limited)
Summary
FDA approved a supplemental application for NEVIRAPINE from Micro Labs Limited (ANDA 203080), authorizing a generic NEVIRAPINE product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NEVIRAPINE (NEVIRAPINE)